These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22991145)

  • 1. Comprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate.
    Koshiyama A; Ichibangase T; Imai K
    Biomed Chromatogr; 2013 Apr; 27(4):440-50. PubMed ID: 22991145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry.
    Imai K; Ichibangase T; Saitoh R; Hoshikawa Y
    Biomed Chromatogr; 2008 Nov; 22(11):1304-14. PubMed ID: 18821527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry.
    Wang Y; Kuramitsu Y; Yoshino S; Takashima M; Zhang X; Ueno T; Suzuki N; Oka M; Nakamura K
    Oncol Rep; 2011 Jul; 26(1):287-92. PubMed ID: 21519797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics.
    Terp MG; Lund RR; Jensen ON; Leth-Larsen R; Ditzel HJ
    Cancer Genomics Proteomics; 2012; 9(5):265-73. PubMed ID: 22990106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
    Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
    J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of an improved proteomics method, fluorogenic derivatization-liquid chromatography-tandem mass spectrometry, to differential analysis of proteins in small regions of mouse brain.
    Asamoto H; Ichibangase T; Uchikura K; Imai K
    J Chromatogr A; 2008 Oct; 1208(1-2):147-55. PubMed ID: 18814880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry.
    Chen JS; Chen KT; Fan CW; Han CL; Chen YJ; Yu JS; Chang YS; Chien CW; Wu CP; Hung RP; Chan EC
    FEBS J; 2010 Jul; 277(14):3028-38. PubMed ID: 20546304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines.
    Ghosh D; Yu H; Tan XF; Lim TK; Zubaidah RM; Tan HT; Chung MC; Lin Q
    J Proteome Res; 2011 Oct; 10(10):4373-87. PubMed ID: 21854069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.
    Tyan YC; Yang MH; Chen SC; Jong SB; Chen WC; Yang YH; Chung TW; Liao PC
    Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2851-62. PubMed ID: 21913264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
    Yocum AK; Busch CM; Felix CA; Blair IA
    J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-glycoprotein analysis discovers new up-regulated glycoproteins in colorectal cancer tissue.
    Nicastri A; Gaspari M; Sacco R; Elia L; Gabriele C; Romano R; Rizzuto A; Cuda G
    J Proteome Res; 2014 Nov; 13(11):4932-41. PubMed ID: 25247386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
    Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
    Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
    Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
    J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.
    Tan HT; Wu W; Ng YZ; Zhang X; Yan B; Ong CW; Tan S; Salto-Tellez M; Hooi SC; Chung MC
    J Proteome Res; 2012 Feb; 11(2):1433-45. PubMed ID: 22181002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
    Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
    Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.